|
|
|
| Influence of Short-term Intensive Insulin Therapy on Expression of TLR4, lL-6, and IL-lβ in Peripheral Blood Mononuclear Cells of Patients with Type-2 Diabetes Mellitus |
| LIAO Zhou-yi, ZHENG Hao-tian, FENG Yi , et al |
| Hemodialysis Center, Department of Nephrology, West China Hospital, Sichuan University , Sichuan Chengdu 610041 |
|
|
|
|
Abstract 【Objective】To explore the influence of short-term intensive insulin therapy (CSII) on toll like receptor-4 (TLR4), interleukin-6 (lL-6), and interleukin-lβ (IL-lβ) expressions in peripheral blood mononuclear cells of patients with type-2 diabetes mellitus (T2DM). 【Methods】A total of 86 cases of patients with T2DM treated in our hospital were selected as the observation group, and 80 cases of healthy volunteers with normal physical examination were selected as the control group. The observation group were given CSII treatment for two weeks. Clinical data such as the peripheral blood glucose (FPG), postprandial 2h blood glucose (2hPG), insulin resistance index (HOMA-IR), triglyceride (TG), total cholesterol (TC), glycosylated hemoglobin (HbAlc) were measured before and after treatment in the observation group. High Density Lipoprotein (HDC-L), Low Density (LDC-L)/High Density Lipoprotein (HDC-L) of the two groups before and after treatment were measured, and TLR4, lL-6, and IL-lβ levels were detected by using reverse transcription polymerase chain reaction (RT-PCR) as well.【Results】After treatment, FPG, 2hPG, HOMA-IR, TG, TC, and HbAlc were all lower than those before the treatment, and the differences were statistically significant (P<0.05). However, compared to the control group, FPG, 2hPG, HOMA-IR, TG, TC, HbAlc levels did not change significantly after treatment (P>0.05). The results of RT-PCR showed that the expressions of TLR4, IL-l beta and lL-6 mRNA in peripheral blood mononuclear cells after treatment were lower than those before treatment (P<0.05);however, compared to the control group, the difference was not significant (P>0.05). 【Conclusion】Short-term intensive insulin therapy (CSII) in the treatment of patients with T2DM can control blood sugar (glucose) and increase insulin sensitivity. It may be related to the inhibition of TLR4, lL-6, and IL-lβ expressions in peripheral blood mononuclear cells.
|
|
Received: 05 July 2017
|
|
|
|
|
|
[1] 熊红霞, 陈维芊, 陈文震. 2型糖尿病并发周围血管病变的临床流行病学研究[J].医学信息, 2016, 29(13):104-105.
[2] 迟志波, 闫萍, 赵红霞. 新诊断2型糖尿病远期血糖控制及改善胰岛β细胞功能的研究:持续皮下胰岛素注射治疗[J].中国糖尿病杂志, 2014, 22(2):154-156.
[3] Puavilai G, Chanprasertyotin S, Sriphrapradaeng A. Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health[J].Diabetes Res Clin Pract,1999, 44(1):21-26.
[4] 吴自强, 叶龙英, 于辉月. 炎症因子、脂质水平与2型糖尿病并发冠心病发病风险分析[J].实验与检验医学, 2016, 34(2):163-165.
[5] 徐爽, 梁琳琅, 李萍,等. T2DM患者糖尿病肾病的危险因素分析[J].热带医学杂志, 2017, 17(3):370-372.
[6] 方伟祯, 蔡振华, 何健,等. 脂代谢紊乱及胰岛素抵抗对2型糖尿病病情的影响[J].山东医药, 2015,55(44):69-70.
[7] 林秀红, 徐明彤, 麦梨芳,等. 短期胰岛素强化治疗对新诊断2型糖尿病患者血浆脂蛋白相关性磷脂酶A2及分泌型磷脂酶A2水平的影响[J].中华内科杂志, 2017, 56(2):127-129.
[8] 师维雅, 何启娟, 左玉琼,等. 果蝇样受体4介导游离脂肪酸诱导2型糖尿病大血管病变的研究[J].中国现代医药杂志, 2014,16(10):1-4.
[9] 潘佳秋, 徐微微, 张超. 新诊断2型糖尿病患者血清高迁移率族蛋白1和Toll样受体4水平变化及其与胰岛素抵抗的关系研究[J].中国全科医学, 2013, 16(3):252-254.
[10] 张超, 潘佳秋, 郭晓闻. 新诊断男女性2型糖尿病患者血清Toll样受体4水平变化及影响因素[J].黑龙江医药科学, 2015, 38(5):6-8.
[11] 张金成, 张力辉, 李新胜,等. 强化胰岛素治疗对2型糖尿病患者血糖及炎症因子的研究[J].中国医药导刊, 2009, 11(10):1699-1700.
[12] 李超, 合湫, 王敏,等. 细胞外信号调节激酶1/2在白介素-1β抑制胰岛β细胞葡萄糖刺激下胰岛素分泌中的作用[J].中国糖尿病杂志, 2015,23(6):558-561.
[13] 张晓丹,叶剑,廖玉婷,等.人α_1-抗胰蛋白酶在胰岛β细胞移植中免疫抑制和保护作用的研究[J].中国病理生理杂志, 2013, 29(4):619-625.
[14] 彭晔,张旭刚,杨秀芳,等.合并2型糖尿病恶性肿瘤患者化疗前后血清IL-6的表达变化[J].军事医学,2014,38(8):645-648.
[15] 刘璠,张趁儒,周慧敏,等.人GLP-1类似物对2型糖尿病患者血清IL-6、TNF-α、CRP及脂联素的影响[J].中国现代医学杂志, 2014, 24(33):27-30.
|
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2018, 35(9): 1734-1735. |
|
|
|
|
2018, Vol. 35 
